Instruction for use: Montelar

Dosage form: Chewing tablets; film-coated tablets

Active substance: Montelukast*

ATX

R03DC03 Montelukast

Pharmacological group:

Anti-inflammatory anti-bronchoconstrictive agent - leukotriene receptor blocker [Prostaglandins, thromboxanes, leukotrienes and their antagonists]

The nosological classification (ICD-10)

J30 Vasomotor and allergic rhinitis: Allergic rhinopathy; Allergic rhinosinusopathy; Allergic diseases of the upper respiratory tract; Allergic rhinitis; Allergic rhinitis seasonal; Vasomotor runny nose; Prolonged allergic rhinitis; All-year-round allergic rhinitis; All-year allergic rhinitis; Year-round or seasonal allergic rhinitis; All-the-year-round rhinitis of an allergic nature; Rhinitis vasomotor allergic; Exacerbation of pollinosis in the form of rhinoconjunctival syndrome; Acute allergic rhinitis; Edema of the nasal mucosa; Edema of the nasal mucosa; Edema of the mucous membrane of the nasal cavity; Swelling of the nasal mucosa; Swelling of the nasal mucosa; Pollinosis; Permanent allergic rhinitis; Rhinoconjunctivitis; Rhinosinusitis; Rhinosinusopathy; Seasonal allergic rhinitis; Seasonal allergic rhinitis; Hay rhinitis; Chronic allergic rhinitis; Allergic diseases of the respiratory tract

J45 Asthma: Asthma of physical effort; Asthmatic conditions; Bronchial asthma; Bronchial asthma of light course; Bronchial asthma with difficulty in sputum discharge; Bronchial asthma of severe course; Bronchial asthma physical effort; Hypersecretory asthma; The hormone-dependent form of bronchial asthma; Curbing asthma attacks with bronchial asthma; Non-allergic bronchial asthma; Night Asthma; Exacerbation of bronchial asthma; Attack of bronchial asthma; Endogenous forms of asthma; Night attacks of asthma; Cough with bronchial asthma

J98.8.0 * Bronchospasm: Bronchospasm with bronchial asthma; Bronchospasm when exposed to an allergen; Bronchospastic reactions; Bronchospastic conditions; Bronchospastic syndrome; Diseases accompanied by bronchospastic syndrome; Reversible bronchospasm; Spasmodic cough

Composition

Tablets chewing - 1 tab.

active substance: Montelukast sodium 4.16 mg; 5.2 mg

(Equivalent to Montelukast - 4 and 5 mg respectively)

Auxiliary substances: mannitol - 155.92 (194.9 mg; MCC - 52.8 / 66 mg; Croscarmellose sodium - 12/15 mg; Giprolose type EXF - 7.2 / 9 mg; Flavoring cherry * - 1,92 / 2,4 mg; Aspartame - 0.96 / 1.2 mg; Cherry flavor additive - 0.48 / 0.6 mg; Dye iron (III) red oxide - 0.36 / 0.45 mg; Magnesium stearate 4.2 / 5.25 mg

* Cherry flavor contains 0.07% of the dye red "Charming" (Allura red AC, E129)

Pharmachologic effect

Mode of action - bronchodilator.

Dosing and Administration

Inside, 1 time per day, before bedtime.

In case of taking the drug in combination with eating food, montelukast should be taken 1 hour before or 2 hours after eating.

The drug is administered to children under the supervision of adults.

For children from 2 to 5 years - 1 chewing tablet at a dose of 4 mg 1 time per day, before bedtime (the use of chewable tablets montelukasta of 4 mg is not recommended at the age of 2 years); From 6 to 14 years - 1 chewable tablet at a dose of 5 mg 1 time per day, before bedtime (the use of chewable tablets Montelar® 5 mg is not recommended until the age of 6 years). The therapeutic effect of montelukast develops during the first day of taking the drug. The patient should continue to take montelukast both during the control period of symptoms of bronchial asthma, and during periods of exacerbation of bronchial asthma.

For prophylaxis in children suffering from bronchospasm caused by physical exertion: from 2 to 5 years - 1 chewable tablet in a dose of 4 mg once a day, before going to bed for 2-4 weeks; From 6 to 14 years - 1 chewable tablet in a dose of 5 mg 1 time per day, before going to bed for 2-4 weeks. In the absence of a satisfactory effect, additional or alternative therapy should be prescribed.

For the treatment of patients older than 15 years and adults, it is recommended to use other dosage forms of montelukast (for example, film-coated tablets, 10 mg).

For patients with renal failure, mild or moderate liver function disorders, and also depending on sex, no special dose selection is required.

Montelukast is not recommended as a monotherapy for patients with moderate to severe bronchial asthma.

Release form

Tablets are chewable, 4, 5 mg. By 7 or 14 table. In the blister pack. By 1, 2, 4 bl. In a cardboard box.

Manufacturer

Sandoz d.d., Slovenia Verovshkova 57, 1000 Ljubljana, Slovenia.

Produced: Sandoz Ilach Sanai Ve Tidjaret AS, Turkey Ataturk Boulevard 9, cad ¹ 1, 41400 Gebze-Kocaeli, Turkey.

A comment

RU1608517170

Terms of leave from pharmacies

On prescription.

Storage conditions of the drug Montelar

In the dark place at a temperature of no higher than 30 ° C, in the original packaging.

Keep out of the reach of children.

Shelf life of the drug Montelar

2 years.

Do not use after the expiry date printed on the package.